Oncolytics Biotech (ONCY) Misses Q3 EPS by 3c

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c